Policy | January 12, 2024
NITI Aayog organises workshop on ‘Strengthening Mental Health Services and Care in India’
The workshop was conducted as a part of the NITI–State workshop series
The workshop was conducted as a part of the NITI–State workshop series
Arco Lab now holds a 50% stake in Neviton
Base4's drug discovery platform allows its collaborators to evaluate billions of novel small molecules to identify and progress RNA-modulators for important diseases
Liraglutide belongs to the class of glucagon like peptide 1 receptor agonist (GLP?1 RA) drugs
Ribo's cutting edge RIBO-GalSTAR platform enables the development of RNAi therapeutics targeting disease-causing genes specifically in hepatocytes
The survey data presented in “The State of the Biopharmaceutical Industry 2024” report reveals that N=21 (18%) of industry professionals were convinced that CGT will dominate as the most important trend in pharma next year
AMI to become part of Enpro’s Sealing Technologies Segment
The company has received marketing authorisation for docetaxel from Israel and cytarabine from Colombia
Transaction delivers KarXT, a first-in-class M1/ M4 muscarinic receptor agonist with differentiated efficacy and safety
Subscribe To Our Newsletter & Stay Updated
